HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Young-Myeong Kim Selected Research

Kangai-1 Protein (Kangai 1 Protein)

1/2017Promoter CpG-Site Methylation of the KAI1 Metastasis Suppressor Gene Contributes to Its Epigenetic Repression in Prostate Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Young-Myeong Kim Research Topics

Disease

61Ischemia
06/2022 - 08/2008
44Neoplasms (Cancer)
10/2021 - 04/2002
39Transient Ischemic Attack
10/2019 - 11/2009
29Inflammation (Inflammations)
03/2021 - 05/2002
17Brain Ischemia (Cerebral Ischemia)
03/2021 - 01/2013
14Hypoxia (Hypoxemia)
10/2022 - 02/2007
13Neoplasm Metastasis (Metastasis)
01/2020 - 06/2005
12Gliosis
01/2021 - 11/2009
10Hyperglycemia
12/2020 - 01/2013
9Reperfusion Injury
03/2021 - 01/2014
9Atherosclerosis
01/2020 - 08/2003
9Melanoma (Melanoma, Malignant)
01/2020 - 06/2005
8Cognitive Dysfunction
08/2020 - 01/2016
7Diabetes Complications
12/2020 - 01/2013
7Vascular Diseases (Vascular Disease)
01/2020 - 07/2006
6Brain Injuries (Brain Injury)
04/2021 - 12/2016
6Ischemic Stroke
02/2020 - 01/2013
5Diabetic Retinopathy (Retinopathy, Diabetic)
02/2021 - 01/2014
5Pre-Eclampsia (Preeclampsia)
01/2020 - 01/2017
4Pathologic Neovascularization
10/2022 - 01/2008
4Prostatic Neoplasms (Prostate Cancer)
01/2019 - 01/2011
4Neurodegenerative Diseases (Neurodegenerative Disease)
04/2018 - 03/2009
4Hepatocellular Carcinoma (Hepatoma)
01/2018 - 05/2006
4Urinary Bladder Neoplasms (Bladder Cancer)
10/2011 - 06/2005
3Alzheimer Disease (Alzheimer's Disease)
06/2022 - 01/2018
3Wounds and Injuries (Trauma)
06/2022 - 01/2014
3Body Weight (Weight, Body)
12/2020 - 11/2009
3Colorectal Neoplasms (Colorectal Cancer)
12/2019 - 12/2009
3Shock
01/2018 - 07/2002
3Leukemia
01/2013 - 02/2010

Drug/Important Bio-Agent (IBA)

32Proteins (Proteins, Gene)FDA Link
03/2021 - 08/2008
28Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2021 - 01/2004
26Neuroprotective AgentsIBA
04/2021 - 08/2008
23salicylhydroxamic acid (SHAM)IBA
01/2021 - 09/2010
16AntioxidantsIBA
03/2021 - 08/2006
16CytokinesIBA
01/2021 - 08/2003
13NF-kappa B (NF-kB)IBA
11/2017 - 07/2003
11Pharmaceutical PreparationsIBA
02/2021 - 01/2004
10Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2018 - 03/2004
8C-PeptideIBA
12/2020 - 01/2013
8Glial Fibrillary Acidic ProteinIBA
02/2019 - 07/2009
8CalciumIBA
12/2015 - 07/2009
7Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
09/2021 - 01/2004
7EnzymesIBA
07/2017 - 03/2009
6Nitric Oxide (Nitrogen Monoxide)FDA Link
06/2022 - 05/2002
6Heme Oxygenase-1IBA
01/2022 - 05/2006
6CU06-1004IBA
01/2020 - 05/2014
6MelatoninIBA
10/2019 - 07/2010
6Brain-Derived Neurotrophic Factor (BDNF)IBA
04/2018 - 06/2011
5Small Interfering RNA (siRNA)IBA
05/2022 - 05/2010
5arginyl-leucyl-tyrosyl-glutamic acidIBA
04/2021 - 02/2017
5Superoxide DismutaseIBA
03/2021 - 03/2011
5Peptides (Polypeptides)IBA
12/2020 - 11/2009
5TetraspaninsIBA
12/2018 - 06/2005
5TransglutaminasesIBA
05/2018 - 03/2009
5Carbon MonoxideIBA
01/2018 - 05/2006
5Glutathione PeroxidaseIBA
07/2017 - 03/2011
5CatalaseIBA
07/2017 - 03/2011
5IntegrinsIBA
01/2017 - 08/2006
5Interleukin-4 (Interleukin 4)IBA
09/2015 - 08/2003
5AntigensIBA
01/2013 - 02/2010
4Oxygen (Dioxygen)IBA
10/2022 - 08/2003
4Streptozocin (Streptozotocin)FDA Link
01/2021 - 01/2013
4MicroRNAs (MicroRNA)IBA
01/2020 - 12/2014
4Messenger RNA (mRNA)IBA
12/2018 - 07/2004
4Transcription Factors (Transcription Factor)IBA
01/2018 - 05/2013
4Nuclear Antigens (Extractable Nuclear Antigens)IBA
06/2017 - 03/2011
4cresyl violetIBA
06/2017 - 05/2011
4Superoxide Dismutase-1IBA
11/2016 - 09/2010
4Reactive Oxygen Species (Oxygen Radicals)IBA
01/2013 - 09/2008
41-phenyl-3,3-dimethyltriazene (PDT)IBA
04/2012 - 11/2009
4Photosensitizing Agents (Photosensitizers)IBA
10/2011 - 11/2009
4chlorinIBA
10/2011 - 11/2009
3CyclinsIBA
03/2021 - 05/2010
3Therapeutic UsesIBA
02/2021 - 12/2019
3Risperidone (Risperdal Consta)FDA LinkGeneric
01/2021 - 06/2014
3NMDA receptor A1IBA
01/2021 - 02/2013
3Blood Glucose (Blood Sugar)IBA
12/2020 - 12/2018
3Anticonvulsants (Antiepileptic Drugs)IBA
04/2020 - 09/2016
3Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
02/2020 - 02/2017
3Biomarkers (Surrogate Marker)IBA
01/2020 - 03/2012
3Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
12/2018 - 05/2014
3Scopolamine (Hyoscine)FDA Link
04/2018 - 01/2018
3Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2017 - 01/2013
3DNA (Deoxyribonucleic Acid)IBA
01/2017 - 01/2013
3deguelinIBA
11/2016 - 11/2015
3N 30IBA
05/2016 - 10/2015
3InterleukinsIBA
09/2015 - 09/2010
3Interleukin-13IBA
09/2015 - 09/2010
3Sodium-Hydrogen ExchangersIBA
04/2015 - 01/2005
3Angiogenesis InhibitorsIBA
08/2014 - 05/2005
3Protein Glutamine gamma Glutamyltransferase 2IBA
01/2013 - 03/2004
3Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
08/2012 - 08/2006
34-hydroxy-2-nonenal (4-hydroxynonenal)IBA
06/2011 - 07/2009
3Membrane Proteins (Integral Membrane Proteins)IBA
01/2011 - 06/2005
3p38 Mitogen-Activated Protein KinasesIBA
01/2010 - 01/2004

Therapy/Procedure

13Therapeutics
01/2020 - 11/2002
4Photochemotherapy (Photodynamic Therapy)
04/2012 - 11/2009
3Drug Therapy (Chemotherapy)
10/2021 - 01/2019
3Intravitreal Injections
05/2018 - 01/2016